{
  "query": "SERPINE1 OR PAI-1 OR plasminogen activator inhibitor-1 OR tiplaxtinin",
  "total_trials": 250,
  "phase_breakdown": {
    "NA": 107,
    "": 46,
    "PHASE4": 35,
    "PHASE3": 22,
    "PHASE2": 19,
    "PHASE1": 8,
    "PHASE1, PHASE2": 6,
    "EARLY_PHASE1": 4,
    "PHASE2, PHASE3": 3
  },
  "status_breakdown": {
    "COMPLETED": 138,
    "UNKNOWN": 48,
    "RECRUITING": 19,
    "ACTIVE_NOT_RECRUITING": 13,
    "TERMINATED": 13,
    "WITHDRAWN": 8,
    "ENROLLING_BY_INVITATION": 6,
    "NOT_YET_RECRUITING": 4,
    "SUSPENDED": 1
  },
  "recent_trials": [
    {
      "NCTId": "NCT00379769",
      "BriefTitle": "RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes",
      "OverallStatus": "COMPLETED",
      "Phase": "PHASE3",
      "Conditions": "Diabetes Mellitus, Type 2",
      "Interventions": "DRUG: Rosiglitazone; DRUG: Sulfonylurea; DRUG: Metformin",
      "StudyType": "INTERVENTIONAL",
      "StartDate": "2001-04",
      "PrimaryCompletionDate": "2008-12",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT06367166",
      "BriefTitle": "Effects of Bioflavanoids on Vascular Wall Remodeling in Patients With Varicose Veins",
      "OverallStatus": "ACTIVE_NOT_RECRUITING",
      "Phase": "NA",
      "Conditions": "Varicose Veins of Lower Limb; Varix; Vascular Diseases; Leg Edema",
      "Interventions": "DRUG: \"Venarus\u00ae\" (diosmin and hesperidin); PROCEDURE: Endovenous laser ablation (EVLA) with miniphlebectomy; OTHER: Elastic compression; OTHER: Evaluation of biomarkers of venous wall remodeling (fibronectin, PAI-1, vimentin, vWF, CD31), venous symptoms and severity scores",
      "StudyType": "INTERVENTIONAL",
      "StartDate": "2023-04-01",
      "PrimaryCompletionDate": "2026-04-01",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT01161394",
      "BriefTitle": "Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study",
      "OverallStatus": "COMPLETED",
      "Phase": "PHASE4",
      "Conditions": "Inflammation",
      "Interventions": "DRUG: Pioglitazone 15mg; DRUG: pioglitazone 30mg; DRUG: placebo",
      "StudyType": "INTERVENTIONAL",
      "StartDate": "",
      "PrimaryCompletionDate": "",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT04262960",
      "BriefTitle": "Effect of Continuous Positive Airway Pressure on Chronotype, Dietary Intake, and Cardiovascular Risk Markers",
      "OverallStatus": "UNKNOWN",
      "Phase": "NA",
      "Conditions": "Obstructive Sleep Apnea of Adult",
      "Interventions": "DEVICE: Device: active CPAP; DEVICE: Device: sham-CPAP",
      "StudyType": "INTERVENTIONAL",
      "StartDate": "2019-08-01",
      "PrimaryCompletionDate": "2020-04",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT00669435",
      "BriefTitle": "Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis",
      "OverallStatus": "UNKNOWN",
      "Phase": "PHASE4",
      "Conditions": "Hypertension",
      "Interventions": "DRUG: Losartan + Simvastatin; DRUG: Amlodipine + Simvastatin",
      "StudyType": "INTERVENTIONAL",
      "StartDate": "2008-04",
      "PrimaryCompletionDate": "2008-04",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT04582188",
      "BriefTitle": "The Early Coagulopathy for the Prognosis in Sepsis",
      "OverallStatus": "UNKNOWN",
      "Phase": "",
      "Conditions": "Sepsis; Coagulopathy; Outcome, Fatal",
      "Interventions": "",
      "StudyType": "OBSERVATIONAL",
      "StartDate": "2020-11-05",
      "PrimaryCompletionDate": "2021-03-31",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT02176941",
      "BriefTitle": "Telomeres and Arterial Aging",
      "OverallStatus": "UNKNOWN",
      "Phase": "",
      "Conditions": "Atherosclerotic Disease",
      "Interventions": "",
      "StudyType": "OBSERVATIONAL",
      "StartDate": "2014-06",
      "PrimaryCompletionDate": "2016-11",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT06051461",
      "BriefTitle": "Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication",
      "OverallStatus": "ACTIVE_NOT_RECRUITING",
      "Phase": "NA",
      "Conditions": "Obesity; Metabolic Syndrome; Metabolic Disorder; Inflammation; Immune System and Related Disorders",
      "Interventions": "DIETARY_SUPPLEMENT: Oral lipid emulsions",
      "StudyType": "INTERVENTIONAL",
      "StartDate": "2023-11-01",
      "PrimaryCompletionDate": "2024-09-01",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT05645887",
      "BriefTitle": "Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.",
      "OverallStatus": "WITHDRAWN",
      "Phase": "PHASE2",
      "Conditions": "Septic Shock",
      "Interventions": "DRUG: Human albumin; OTHER: Saline solution",
      "StudyType": "INTERVENTIONAL",
      "StartDate": "2024-02",
      "PrimaryCompletionDate": "2024-05-23",
      "Enrollment": ""
    },
    {
      "NCTId": "NCT06382298",
      "BriefTitle": "Cottonseed Oil Versus Matched PUFA Effects",
      "OverallStatus": "RECRUITING",
      "Phase": "NA",
      "Conditions": "Dyslipidemia; Overweight and Obesity; Nutrition, Healthy",
      "Interventions": "OTHER: COTTONSEED OIL; OTHER: MATCHED PUFA DIET; OTHER: CONTROL",
      "StudyType": "INTERVENTIONAL",
      "StartDate": "2024-08-31",
      "PrimaryCompletionDate": "2026-12",
      "Enrollment": ""
    }
  ]
}